Avexegen Therapeutics Inc. an innovative biotechnology company developing novel therapies for gastrointestinal disorders secures exclusive global license for Neuregulin4.San Diego CA PRWEB March 20 2017 Avexegen Therapeutics Inc. an innovative biotechnolo...
↧